[1]
J. Chen and W. Wang, “Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Malignant Tumors: Mechanistic Insights, Clinical Efficacy, and Emerging Optimization Strategies”, IJBLS, vol. 11, no. 3, pp. 62–65, Aug. 2025, doi: 10.54097/jdh0fj75.